Skip to main content
Log in

What factors affect the PSA relapse-free survival times in patients treated with permanent seed brachytherapy?

  • Practice Point
  • Published:

From Nature Clinical Practice Urology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lin K et al. (2007) Improvements in prostate brachytherapy dosimetry due to seed stranding. Brachytherapy 6: 44–48

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert E Reiter.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reiter, R., Riggs, S. What factors affect the PSA relapse-free survival times in patients treated with permanent seed brachytherapy?. Nat Rev Urol 4, 650–651 (2007). https://doi.org/10.1038/ncpuro0965

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0965

  • Springer Nature Limited

Navigation